P

Inventor

JANNE PASI

US17 patents
⚠️ This page may combine multiple inventors who share the name “JANNE PASI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DANA FARBER CANCER INST INC

16 patents
US10385019B2Aug 20, 2019

Inhibitors of EGFR and methods of use thereof

DANA FARBER CANCER INST INC2 citations72
US10266517B2Apr 23, 2019

Pyrimidines as EGFR inhibitors and methods of treating disorders

DANA FARBER CANCER INST INC2 citations72
US10450310B2Oct 22, 2019

Bifunctional molecules for degradation of EGFR and methods of use

DANA FARBER CANCER INST INC5 citations71
US12331037B2Jun 17, 2025

Pyrimidines as EGFR-inhibitors and methods of treating disorders

DANA FARBER CANCER INST INC0 citations62
US11673882B2Jun 13, 2023

Pyrimidines as EGFR inhibitors and methods of treating disorders

DANA FARBER CANCER INST INC0 citations62
US10836722B2Nov 17, 2020

Inhibitors of EGFR and methods of use thereof

DANA FARBER CANCER INST INC1 citations62
US11858897B2Jan 2, 2024

Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK

DANA FARBER CANCER INST INC0 citations60
US11161842B2Nov 2, 2021

Bifunctional molecules for degradation of EGFR and methods of use

DANA FARBER CANCER INST INC0 citations60
US11066363B2Jul 20, 2021

Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK

DANA FARBER CANCER INST INC0 citations60
US11945816B2Apr 2, 2024

Inhibitors of EGFR and/or HER2 and methods of use

DANA FARBER CANCER INST INC0 citations58
US11186574B2Nov 30, 2021

Inhibitors of EGFR and/or HER2 and methods of use

DANA FARBER CANCER INST INC0 citations58
US10870636B2Dec 22, 2020

Pyrimidines as EGFR inhibitors and methods of treating disorders

DANA FARBER CANCER INST INC0 citations51
US10508082B2Dec 17, 2019

Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK

DANA FARBER CANCER INST INC0 citations51
US11814379B2Nov 14, 2023

Cyano quinoline amide compounds as HER2 inhibitors and methods of use

DANA FARBER CANCER INST INC0 citations50
US11584746B2Feb 21, 2023

Inhibitors of EGFR and methods of use thereof

DANA FARBER CANCER INST INC0 citations47
US10550112B2Feb 4, 2020

Pyrimidines as EGFR inhibitors and methods of treating disorders

DANA FARBER CANCER INST INC0 citations41

GRAY NATHANAEL S

1 patent